Rehabilitation Robots Market by Type (Therapeutic Robots, Exoskeleton Robots, Assistive Robots), and End User (Hospitals & Clinics, Rehabilitation Center) – Global Outlook & Forecast 2022-2030
According to a deep-dive market assessment study conducted by Growth+ Reports, the global rehabilitation robots market was estimated at US$ 1,168.64 million in 2021 and is expected to witness a CAGR of 19.2% from 2022 to 2030.
Rehabilitation is a designed treatment used in physical recovery process; it helps in improving the physical abilities of patients to achieve their maximum potential for physical and psychological function in social life. In the rehabilitation process, different robots are utilized according to their functional requirements. The use of robots in the field of patient rehabilitation has several advantages over conventional rehabilitation practices. Production of repetitive improved physical movements, improved rehabilitation outcomes, and better precision are some of the key benefits availed from the use of rehabilitation robots.
Rapidly aging population and increasing cases of neurological conditions and musculoskeletal injuries form the key drivers of the global rehabilitation market. Furthermore, the growing application of IoMT (Internet of Medical Things) and AI in robotic rehabilitation is considered another major factor in propelling the growth of the market. Vast applications and regular innovations in technology using AI provide automation in the system which in turn offers improved treatment outcomes. For instance, in Dec 2021, Inrobics Social Robotics launched an AI-based robotic device to provide and improve motor and cognitive rehabilitation services for use at health centers and homes. It includes four basic elements such as the robotic interaction with the patient, an AI system to control the robot, an application for use by health care staff for a systematic procedure of the sessions, and a cloud-based storage system that includes information and analytics from all the rehabilitation processes.
Another trend that can affect the market is increasing stroke cases which could play a key role in dysfunctionality or immobility in the diseased individual. For instance, according to the CDC (Centers for Disease Control and Prevention) organization, every year more than 795,000 people in the United States have a stroke. About 610,000 of these are first or new strokes with nearly
87% are ischemic strokes, in which blood flow to the brain is blocked which causes serious long-term disability and reduced mobility.
However, the high cost of the robots due to the upgradation or innovations in the technology for the automation can restrict the adoption rate in several areas, as it may be expensive in terms of its maintenance and services, which in turn also affects the prices of the treatments and consequently rise in the cost of treatment.
Asia Pacific will have definite development and is estimated to be the fastest-growing region in the market globally. The market growth in Asia Pacific is mainly influenced by the increasing number of traumatic patients and the growth in technological automations in robotic therapy to treat patients. For instance, according to the Global Burden of Disease Study 2019, China was one of the leading countries witnessing stroke cases, globally. In 2019 alone, China witnessed around 3.94 million new stroke cases, 28.76 million prevalent cases, and 2.19 million deaths due to stroke in 2019. Furthermore, stroke also played a key role in the cause of disability-adjusted life-year (DALY) in China, the number of DALYs reached approximately 45.9 million in 2019.
Among the different rehabilitation robots types, exoskeletons is anticipated to hold a significant share in the global market. These devices are intended to augment overall strength of ailing patients and restore movement. Exoskeletons are also observed to be an excellent choice of rehabilitation in patients with stroke, Parkinson’s and other neurodegenerative conditions, as these conditions often compromise the normal body movements and thus interfere with daily activities. Furthermore, exoskeletons are also exhibiting significant potential in rehabilitation from spinal cord injuries. Solutions such as ReWalk are already FDA approved and are used for activities as standing upright, climbing and turning. Further technological advancements in this segment and cost containment in products will lead to additional penetration of exoskeletons in mainstream rehabilitation and expanded application base.